KLRC1 (or NKG2A) is an inhibitory receptor for both CD8 + cytotoxic T cells and NK cells and is predominantly expressed by CD8 + T cells in human lung cancer where their presence is correlated with the progression of chronic infection and cancer14. Here, CD8A is linked to lung cancer.